VOLUME 13 | NUMBER 10 | OCTOBER 2010 nature neurOSCIenCe a r t I C l e S It is well established that NMDARs are important triggers for the induction of both long-term potentiation (LTP) 1-3 and LTD [4] [5] [6] [7] . These two forms of synaptic plasticity involve alterations in the excitatory postsynaptic current (EPSC) that is mediated via the activation of AMPA receptors (AMPARs). In addition, it is now clear that NMDARmediated LTP and LTD also involve alterations in NMDAR-mediated EPSCs 8 . These alterations in NMDAR-mediated synaptic transmission will affect the ability of synapses to undergo subsequent synaptic plasticity and therefore represent an important form of metaplasticity 9 . The mechanism by which the synaptic activation of NMDARs results in LTP and LTD of AMPAR-and NMDAR-mediated synaptic transmission is only partially understood, although a major component appears to involve alterations in the trafficking of these receptors to and from synapses 10 .
a r t I C l e S
It is well established that NMDARs are important triggers for the induction of both long-term potentiation (LTP) [1] [2] [3] and LTD [4] [5] [6] [7] . These two forms of synaptic plasticity involve alterations in the excitatory postsynaptic current (EPSC) that is mediated via the activation of AMPA receptors (AMPARs). In addition, it is now clear that NMDARmediated LTP and LTD also involve alterations in NMDAR-mediated EPSCs 8 . These alterations in NMDAR-mediated synaptic transmission will affect the ability of synapses to undergo subsequent synaptic plasticity and therefore represent an important form of metaplasticity 9 . The mechanism by which the synaptic activation of NMDARs results in LTP and LTD of AMPAR-and NMDAR-mediated synaptic transmission is only partially understood, although a major component appears to involve alterations in the trafficking of these receptors to and from synapses 10 .
The molecular processes that couple NMDAR activation to alterations in the synaptic expression of AMPARs and NMDARs are probably best understood for LTD of AMPAR-mediated synaptic transmission (NMDAR-LTD A ) in the hippocampus 7 . This process is triggered by a protein phosphatase cascade that involves PP2B and PP1 (refs. 11,12) and activation of kinases, such as glycogen synthase kinase-3 (refs. 13, 14) , the membrane targeting of the high-affinity neuronal calcium sensor (NCS) protein hippocalcin 15 and alterations in MAGUK proteins, in particular PSD-95 (refs. 16, 17) .
The activation of muscarinic receptors may also be important for synaptic plasticity. It has been shown that pharmacological activation of these receptors can potentiate the activation of NMDARs 18, 19 and can facilitate the induction of NMDAR-LTP 20 . In addition, activation of muscarinic receptors can both facilitate the induction of NMDAR-LTD 21 and induce an NMDAR-independent form of LTD 22 . However, most of the previous studies have activated muscarinic receptors by applying an agonist, such as carbachol (CCh), with very few studies of how, or indeed whether, the synaptic release of acetylcholine (ACh) can influence synaptic plasticity via the activation of muscarinic receptors 23 .
We identified a direct and powerful interaction between NMDA and mACh receptor systems. We found that the activation of mAChRs induces LTD of NMDAR-mediated synaptic transmission (termed mAChR-LTD N ) by causing a dynamin-dependent internalization of NMDARs. This process can be readily triggered by application of a muscarinic agonist or by the synaptic release of ACh. It involves a signaling cascade in which the stimulation of muscarinic receptors results in IP 3 -mediated Ca 2+ release from intracellular stores, activation of hippocalcin and alterations in the association of AP2 and PSD-95 with NMDARs.
RESULTS

CCh induces LTD on NMDAR-mediated synaptic transmission
Unless otherwise stated, all experiments were performed on acutely prepared rat hippocampal slices. NMDAR-mediated EPSCs (EPSC N ) were evoked by stimulation of Schaffer collateral-commissural fibers and recorded from CA1 neurons, held at −40 mV, following blockade of AMPAR-and GABAR-mediated responses. Bath application of CCh (50 μM, 10 min) induced LTD of EPSC N (61 ± 5% of baseline measured 36 min after the end of the application, n = 6; Fig. 1a) . Application of pirenzepine (0.5 μM), an antagonist of the M1 subtype of mAChRs, eliminated this LTD (97 ± 4%, n = 7, P < 0.01 versus a r t I C l e S control LTD; Fig. 1a) , leaving a reversible depression, which was presumably a result of activation of a different muscarinic receptor subtype 24 . An M1-selective agonist (77-LH-28-1, 10 μM) induced a similar long-lasting depression without inducing the transient depression and its effects were eliminated by pirenzepine (77-LH-28-1, 64 ± 6%, n = 6; pirenzepine, 95 ± 6%, n = 6; Fig. 1b) . These results indicate that activation of muscarinic receptors can induce LTD of EPSC N that is dependent on the activation of M1 receptors.
We explored the mechanism of this form of LTD, termed CCh-LTD N , by introducing various agents into the recorded neuron using the patch pipette (Fig. 1c-h) . None of the agents used affected basal NMDAR-mediated synaptic transmission or input resistance (data not shown). We found that CCh-LTD N required postsynaptic Ca 2+ , as it was inhibited by 10 mM BAPTA (92 ± 4%, n = 6; Fig. 1c) . Because M1 receptors couple to the phosphoinositide pathway, it is likely that the Ca 2+ source is IP 3 -triggered Ca 2+ released from intracellular stores. Consistent with an involvement of this canonical signaling pathway, LTD was blocked by 10 μM ryanodine (98 ± 3%, n = 6; Fig. 1d ) and the IP 3 receptor antagonist 2-aminoethoxydiphenyl borate (2-APB, 10 μM, 97 ± 3%, n = 6; Fig. 1e) . The other limb of the phosphoinositide pathway does not seem to be required, however, as a PKC inhibitor that effectively blocks mGluR-LTD 25 was without effect (10 μM, Ro 32-0432, 64 ± 4%, n = 5; Fig. 1f) . As the prototypic form of LTD, induced by the activation of NMDARs, involves activation of the protein phosphatases PP1 and PP2B 11 , we also tested inhibitors of these proteins, but found no effect (100 nM okadaic acid, 62 ± 6%, n = 5; 10 μM ciclosporin, 63 ± 4%, n = 5; Fig. 1g,h) . These results suggest that CCh-LTD N involves IP 3 -mediated release of Ca 2+ from intracellular stores that then activates a nonclassical mechanism.
LTD N can be induced via the synaptic activation of mAChRs Although the stimulation of muscarinic receptors using an agonist is useful for performing biochemical experiments and is relevant to how these cholinergic agents may act in the brain when administered therapeutically, the physiological relevance of such plasticity is questionable. We therefore investigated whether LTD N could be induced by the synaptic activation of muscarinic receptors. We delivered pairedpulse low-frequency stimulation (PP-LFS, 200 paired-pulses (50-ms interval) at 1 Hz) 26 in an attempt to activate the cholinergic fibers present in acute hippocampal slices and held neurons at −40 mV so that we could simultaneously measure both the fast component of the EPSC (EPSC F ) and the tail component of the EPSC (EPSC T ) (Fig. 2a,b) . Synaptic activation induced both LTD F (63 ± 4%, n = 6; Fig. 2a ) and LTD T (68 ± 4%, n = 6; Fig. 2b) , the induction of which was blocked by the addition of pirenzepine (EPSC F , 105 ± 3%, n = 6; EPSC T , 111 ± 9%, n = 6; Fig. 2a,b) or telenzepine (EPSC F , 100 ± 7%, n = 6; EPSC T , 105 ± 5%, n = 6; Fig. 2a,b) .
As there is inevitably some temporal overlap between AMPARmediated EPSCs (EPSC A ) and EPSC N , we performed all subsequent experiments after blocking AMPARs using NBQX. Because the synaptic activation of group I mGluRs can potentially induce LTD of NMDAR-mediated synaptic transmission 27, 28 we also routinely blocked group I mGluRs by continuous perfusion of YM 298198 and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) to eliminate the activation of mGlu 1 and mGlu 5 receptors, respectively. We then applied d-2-amino-5-phosphonopentanoate (AP5) to inhibit NMDARs and, while synaptic transmission was fully blocked, delivered PP-LFS ( Fig. 2c-h ). This strategy succeeded in activating a synaptic form of AChR-LTD N , as there was an LTD that was specific to the conditioned input following AP5 washout (PP-LFS input, 69 ± 4%; control input, 101 ± 4%, n = 5; Fig. 2c ). This synaptically induced LTD of EPSC N was similar in appearance to that induced by CCh and was prevented by the addition of pirenzepine (95 ± 6%, n = 5; Fig. 2d ). Thus, it is possible to induce a robust LTD N by the synaptic activation of muscarinic receptors (termed, syn-mAChR-LTD N ). Similar to CCh-LTD N , synmAChR-LTD N was also blocked by inclusion in the patch pipette of BAPTA (102 ± 8%, n = 6; Fig. 2e ), ryanodine (98 ± 6%, n = 6; Fig. 2f ) and 2-APB (98 ± 5%, n = 6; Fig. 2g ), but not Ro-32-0432 (73 ± 4%, n = 6; Fig. 2h ).
Hippocalcin is involved in mAChR-LTD N Having established that both CCh-LTD N and syn-mAChR-LTD N are dependent on postsynaptic Ca 2+ , we sought to determine the nature of the Ca 2+ -sensitive steps involved (Fig. 3) . As calmodulin is an important calcium sensor involved in synaptic plasticity, we tested a peptide inhibitor of this protein based on the calmodulin-binding domain of myosin light chain kinase (MLCK, 10 μM) (Fig. 3a-c) , which effectively blocks NMDAR-dependent LTD in the perirhinal a r t I C l e S cortex 25 . However, this MLCK peptide had no effect on either CCh-LTD N (65 ± 3%, n = 5; Fig. 3a ) or syn-mAChR-LTD N (64 ± 5%, n = 6; Fig. 3b ), although it did block NMDAR-LTD A (Fig. 3c) . Another Ca 2+ -sensitive protein that has been shown to be involved in synaptic plasticity is hippocalcin 15 , a member of the NCS family that is highly expressed in the hippocampus 29 . The role of hippocalcin can be explored using a well-characterized dominant-negative protein (GST-Hip 2-72 ), which is an N-terminal truncation that lacks the Ca 2+ binding sites 15 . Treatment with the dominant-negative protein selectively blocked mAChR-LTD N ( Fig. 3d-h ). Thus, postsynaptic infusion of GST-Hip 2-72 blocks CCh-LTD N , whereas GST alone had no effect in interleaved experiments (40 nM GST-Hip 2-72 , 104 ± 3%, n = 5; 40 nM GST, 63 ± 7%, n = 5; P < 0.05; Fig. 3e ). Similarly, GST-Hip 2-72 blocked syn-mAChR-LTD N , but GST alone had no effect (GST-Hip 2-72 , 99 ± 9%, n = 5; GST, 62 ± 5%, n = 5; Fig. 3f ). The effect of GSTHip 2-72 was a result of blockade of the induction of LTD N rather than of occlusion of the process, as baseline transmission was not affected (97 ± 10%, n = 5; Fig. 3d ). The effect was also selective for NMDARs, as GST-Hip 2-72 had no effect on mAChR-LTD A induced by either CCh (66 ± 4%, n = 5; Fig. 3g ) or synaptic stimulation (66 ± 5%, n = 5; Fig. 3h ). These results indicate that hippocalcin is required for the LTD N that can be induced by the activation of muscarinic receptors. Although the GST-Hip 2-72 dominant negative is an established tool for investigating the function of hippocalcin, it could have other actions. We therefore used a previously characterized RNAi probe that efficiently knocks down the expression of hippocalcin 25 . We generated hippocalcin RNA interference (Hip-RNAi) constructs and tested their efficacy in cultured hippocampal neurons by immunocytochemistry. Hip-RNAi greatly suppressed the expression of hippocalcin, whereas luciferase RNAi had no effect (Fig. 4a) . As a control, we tested the effects of Hip-RNAi on the expression of PSD-95 and observed no effect (Fig. 4b) .
We then studied synaptic function in organotypic slice cultures ( Fig. 4c-f) . To investigate the effects of hippocalcin knockdown on synaptic transmission, we performed simultaneous recordings of EPSCs from Hip-RNAi-transfected and neighboring nontransfected neurons. Hip-RNAi caused a small reduction of EPSC N , but there were no significant differences in EPSC A between Hip-RNAitransfected cells and neighboring nontransfected cells (EPSC N in transfected cells, 222 ± 17 pA; EPSC N in nontransfected cells, 286 ± 14 pA; n = 20 pairs, P < 0.01; EPSC A in transfected cells, 177 ± 15 pA; EPSC A in nontransfected cells, 192 ± 18 pA; n = 20 pairs, P > 0.05; Fig. 4c ). We next investigated whether Hip-RNAi had any effect on CCh-LTD N . Consistent with the results of our GST-Hip 2-72 experiments, transfection of Hip-RNAi blocked CCh-LTD N , whereas CCh-LTD N was routinely induced in simultaneously recorded, neighboring nontransfected cells (Hip-RNAi, 99 ± 9%, n = 5; nontransfected, 63 ± 4%; n = 5, P < 0.05; Fig. 4d ). We confirmed that CCh-LTD N in organotypic slices was likely to be the same form of synaptic plasticity as CCh-LTD N in acute slices by demonstrating sensitivity to pirenzepine (96 ± 8%, n = 6; a r t I C l e S GST-Hip 2-72 on mAChR-LTD A , Hip-RNAi had no effect on CCh-LTD A (62 ± 3%, n = 6, P > 0.05 versus control; Fig. 4f ), confirming the selective involvement of hippocalcin in LTD of NMDAR-mediated synaptic transmission when muscarinic receptors are activated.
mAChR-LTD N involves internalization of NMDARs
We then examined the locus of expression of mAChR-LTD N . As other forms of LTD involve the internalization of receptors 10 , we investigated whether CCh-LTD N might involve internalization of NMDARs using surface biotinylation experiments. Hippocampal slices were treated with CCh (10 min), in the presence or absence of pirenzepine, and the cell surface and total expression levels of the GluN1 subunit of the NMDAR were compared (Fig. 5a) . CCh reduced surface GluN1 expression (55 ± 1% of control, n = 4, P < 0.05 versus control) without affecting the total expression of GluN1 in a pirenzepinesensitive manner (121 ± 21% of control, P > 0.05 versus control). If the internalization of NMDARs is indeed the expression mechanism involved in mAChR-LTD N , then preventing endocytosis should inhibit this form of LTD. Because most forms of receptor endocytosis that have been associated with LTD are dynamin dependent, we used dynasore, an inhibitor of this process. Dynasore blocked both CCh-LTD N (98 ± 4%, n = 6; Fig. 5b ) and syn-mAChR-LTD N (102 ± 6%, n = 5; Fig. 5c ) in acute hippocampal slices. A robust biochemical correlate of mAChR-LTD N enabled us to explore the molecular mechanisms involved in more detail. As hippocalcin interacts with the clathrin adaptor protein AP2 (ref. 15 ) and AP2 is involved in the internalization of NMDARs, where it might compete with PSD-95 (ref. 30) , we investigated the interactions of these three molecules with NMDAR subunits, using coimmunoprecipitation assays (Fig. 6a) . CCh increased the association between GluN1 and the β-adaptin subunit of AP2 and reduced the association between GluN1 and PSD-95. Hippocalcin co-immunoprecipitated with GluN1 and PSD-95 under basal conditions. CCh caused a substantial reduction in this association (Fig. 6b) without affecting the association between hippocalcin and β-adaptin (Fig. 6c) . CCh also had no effect on protein expression levels of PSD-95, GluN1 and β-adaptin (Fig. 6d) . These data indicate that dynamic interactions occur between hippocalcin, AP2 and PSD-95 and that these interactions may be associated with the internalization of NMDARs that is triggered by the activation of muscarinic receptors.
Hippocalcin interacts with the SH3 domain of PSD-95
To examine whether hippocalcin can directly interact with NR1 or PSD-95, we employed a mammalian two-hybrid assay system 31 (Fig. 7a,b) . We prepared VP16AD-tagged constructs of C-terminal (Fig. 7a) . Truncated hippocalcin was tagged with GAL4BD protein (BD-Hip 2-72 , BD-Hip ; Fig. 7a ). Luciferase assays indicated that the N-terminal region of hippocalcin (Hip 2-72 ) strongly interacted with the AD-95SHGK construct and weakly interacted with the AD-95PDZ construct, whereas the C-terminal region of hippocalcin did not interact with either construct. Neither part of hippocalcin interacted with the C-terminal region of GluN1 (Fig. 7b) . Consistent with mammalian two-hybrid experiments, GST pull-down assays also confirmed that Hip 2-72 interacted with the SHGK domain of PSD-95 more strongly than the PDZ domain (Fig. 7c) . In addition, Hip 2-72 did not interact with SH3-deleted PSD-95 (95ΔSH3), but interacted with PSD-95 that lacked the guanylate kinase-like domains (95ΔGK ; Fig. 7d ). These results suggest that hippocalcin specifically interacts with the SH3 domain of PSD-95.
If this interaction has any functional importance, it would be expected that the interaction might vary according to Ca 2+ concentration, particularly over the nanomolar concentration range in which hippocalcin senses Ca 2+ . We therefore carried out GST-hippocalcin pull-down assays using hippocampal lysates and a range of free [Ca 2+ ]. There was a strong association of hippocalcin with both PSD-95 and GluN1 at a free [Ca 2+ ] of 10 −8 M. This association decreased markedly over the concentration range (10 −7 to 10 −5 M) that hippocalcin senses Ca 2+ (Fig. 7e) . These data are consistent with hippocalcin decreasing its association with the NMDAR complex on sensing Ca 2+ .
The SH3 domain of PSD-95 is required for mAChR-LTD N To further determine the region of PSD-95 that is involved in the interaction and to establish the functional importance of this interaction, we used RNAi to knockdown endogenous PSD-95 and coexpressed a variety of RNAi-resistant PSD-95 constructs (PSD-95 RNAiRs) using slice cultures (Fig. 8) . In paired-cell recordings 25 Coexpression with an RNAi-resistant form of PSD-95 that lacked the guanylate kinase-like domains (ΔGKPSD-95 RNAiR) and PSD-95-RNAi had very similar effects. Thus, this treatment increased basal EPSC N (ΔGKPSD-95 RNAiR, 227 ± 16 pA, n = 14; nontransfected cells, 178 ± 19 pA, n = 14, P < 0.05; Fig. 8e, left) and EPSC A (ΔGKPSD-95 RNAiR, 296 ± 20 pA, n = 14; nontransfected cells, 192 ± 22 pA, n = 14; P < 0.01; Fig. 8e ) and LTD N was again rescued (ΔGKPSD-95 RNAiR, 68 ± 5%; nontransfected, 67 ± 4%, n = 5; P > 0.05; Fig. 8f) . In contrast, an RNAi-resistant form of PSD-95 lacking the SH3 domain (ΔSHPSD-95 RNAiR) had very different effects. Although, similar to the other constructs, it increased AMPAR-mediated synaptic transmission (ΔSHPSD-95 RNAiR, 256 ± 18 pA, n = 18; nontransfected cells, 138 ± 17 pA, n = 18; P < 0.01; Fig. 8g) , it did not affect NMDAR-mediated synaptic transmission (ΔSHPSD-95 RNAiR, 138 ± 18 pA, n = 18; nontransfected cells, 145 ± 14 pA, n = 18; P > 0.05; Fig. 8g) . Notably, it was unable to rescue the deficit in LTD N (ΔSHPSD-95 RNAiR, 96 ± 5%; nontransfected cells, 63 ± 4%, n = 5; P < 0.05; Fig. 8h) . These experiments confirm and extend the biochemical studies by identifying the SH3 domain of PSD-95 as being important for mAChR-LTD N .
DISCUSSION
It is well established that, as with AMPAR-mediated synaptic transmission, NMDAR-mediated synaptic transmission is highly plastic and can readily undergo both LTP and LTD 35 . However, this plasticity is generally induced by the synaptic release of l-glutamate acting on ionotropic or metabotropic glutamate receptors. Our finding that the synaptic activation of muscarinic receptors can readily induce LTD of NMDAR-mediated synaptic transmission adds a new dimension to the plastic capabilities of the brain.
A role for hippocalcin in mAChR-LTD N A principal mechanistic finding of our study is that hippocalcin is required for mAChR-LTD N . Hippocalcin is uniquely suited to this role as it has a high affinity for Ca 2+ Figure 6 Dynamic interactions between NMDARs, hippocalcin, AP2 and PSD-95. (a) Co-immunoprecipitation assays revealed that CCh caused an increased association of β-adaptin and a decreased association of PSD-95 with NMDARs. The association of NR1 and NR2 subunits did not change.
(b) Co-immunoprecipitation assays showed that hippocalcin associated with the NMDAR complex and that CCh caused its disassociation. (c) CCh had no effect on the association between hippocalcin and β-adaptin. CCh (50 μM) was applied to hippocampal slices for 10 min at t = 0. (d) CCh had no effect on the total protein expression levels of PSD-95, GluN1 and β-adaptin. Histograms show the quantification from at least three independent experiments. *P < 0.05 and **P < 0.01 versus control. Error bars represent mean ± s.e.m. a r t I C l e S members of the NCS family, undergoes a conformational change on binding Ca 2+ to expose its myristoylated region, which then leads to its targeting to the plasma membrane 29 . Notably, hippocalcin seems to use this unique property for several different neuronal functions. Thus, it has been found to be involved in the endocytosis of AMPARs following the stimulation of NMDARs 15 and in the Ca 2+ activation of certain K + channels 36 . However, hippocalcin is not involved in all types of synaptic plasticity. For example, we found that it did not mediate mAChR-LTD A . This result, which at first might seem surprising in light of the role of hippocalcin in NMDAR-mediated LTD A 15 , is consistent with the fact that CCh-LTD A is a Ca 2+ -independent form of synaptic plasticity 22 . Thus, the involvement of hippocalcin neither correlates with the receptor involved in induction nor with the receptor involved in expression of synaptic plasticity. It clearly has a complex role depending on the form of plasticity, which presumably relates, at least in part, to the precise requirements for Ca 2+ and perhaps the microdomains in which the different forms of synaptic plasticity operate. It is possible that mAChR-LTD N and NMDAR-LTD A operate in different types of spine, given that the former requires IP 3 -mediated Ca 2+ release from intracellular stores and that this apparatus might only exist in a subset of spines 37 .
The mechanism of expression of mAChR-LTD N appears to be the internalization of NMDARs. This suggestion is supported by the finding that dynasore, which blocks dynamin-dependent internalization 38 , eliminates mAChR-LTD N and that carbachol treatment leads to an M1 mAChR-dependent internalization of NMDARs. It is known that NMDARs can undergo clathrin-mediated endocytosis, but the trigger for and functional importance of this process was unknown. Previous work has shown that PSD-95 and β-adaptin can bind to a similar region of the intracellular tail of GluN2B subunits and it has been suggested that the function of PSD-95 might be to inhibit clathrin-mediated endocytosis 30 . Our results provide further experimental support for this hypothesis and identify a potential molecular mechanism. We suggest that Ca 2+ release from intracellular stores, resulting from the stimulation of muscarinic receptors, triggers hippocalcin to initiate an exchange of β-adaptin for PSD-95 at NMDARs, thereby initiating their endocytosis (Supplementary Fig. 1) .
A role for PSD-95 in mAChR-LTD N Previous studies have shown that PSD-95 regulates NMDAR surface expression 30 and is involved in NMDAR-LTD A 16,17,39,40 . In particular, this form of LTD requires dephosphorylation of ser295, a residue in a linker region between the PDZ domains 2 and 3 (ref. 16 ). It also involves interactions with the SH3 and guanylate kinase-like domains, where one function might be to associate with calcineurin, via an interaction with AKAP79/150, so that this enzyme is located a r t I C l e S close to NMDARs 17 . Our findings indicate that the involvement of PSD-95 is not restricted to this one form of LTD, but rather it extends to LTD triggered via the activation of a G protein-coupled receptor (in this case the muscarinic receptor) and is expressed by changes in NMDAR-mediated synaptic transmission. Using a similar knockdown and replacement strategy to that employed previously 17 , we found that the SH3 domain of PSD-95 is involved in mAChR-LTD N .
One possible mechanism that could explain our results is that hippocalcin binds to the SH3 domain of PSD-95 under basal conditions (Supplementary Fig. 1 ). On binding Ca 2+ , hippocalcin translocates to the plasma membrane, permitting the disassociation of PSD-95 from NMDARs. This would then enable AP2, which is itself targeted to the vicinity of the plasma membrane by hippocalcin, to bind NMDARs and initiate their endocytosis. Consistent with this model, the PSD-95 mutant that lacks the SH3 domain was still able to bind NMDARs, but was unable to bind hippocalcin. Also consistent with this model, the dominant-negative hippocalcin blocked the process, as it would bind to PSD-95, but would not dissociate in response to a rise in Ca 2+ .
In addition to its role in LTD, it is well established that PSD-95 can regulate AMPAR-mediated synaptic transmission by promoting insertion of AMPARs at synapses 32, 41, 42 . It has been suggested that this effect and the effect on LTD involve different interaction sites in PSD-95 (ref. 17) . Our findings support the view that the functions of PSD-95 on baseline synaptic transmission and synaptic plasticity can be dissociated, as all three forms of PSD-95 that we expressed increased AMPAR-mediated synaptic transmission, but only the SH3 domain mutant blocked mAChR-LTD N . The effect of PSD-95 expression on NMDAR-mediated synaptic transmission is less clear, with reports of small increases 34 or no effect 17 . We observed a small increase in EPSC N with overexpression of wild-type PSD-95 and the PDZ domain mutant, but no change with the SH3 domain mutant. This suggests that the effects on NMDAR-mediated synaptic transmission and synaptic plasticity of EPSC N might be related. For example, the inhibition of LTD over a period of a few days might have led to the small increase in synaptic transmission, a likely scenario if synaptic transmission is set by a balance of ongoing LTP and LTD. However, the complete block of LTD cannot be attributed to the small increase in synaptic transmission. The most compelling evidence in support of this is that the dominant-negative protein applied via the patch pipette eliminated LTD without affecting baseline transmission. These findings emphasize the importance of complementary strategies (in this case, dominant negative and RNAi) for understanding the functions of proteins in synaptic plasticity.
Our results identify a previously unknown form of synaptic plasticity in which the activation of NMDARs can be depressed for long periods of time by the activation of muscarinic receptors. These results suggest a mechanism of synaptic plasticity that involves an interaction between NMDARs, hippocalcin, AP2 and PSD-95.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
